JNJ - Johnson & Johnson

NYSE - Nasdaq Real Time Price. Currency in USD
+1.04 (+0.81%)
As of 10:46AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close129.14
Bid130.610 x 800
Ask130.710 x 1400
Day's Range129.77 - 132.80
52 Week Range118.62 - 148.99
Avg. Volume8,590,264
Market Cap349.14B
Beta (3Y Monthly)0.32
PE Ratio (TTM)228.79
EPS (TTM)0.569
Earnings DateJan 22, 2019
Forward Dividend & Yield3.60 (2.71%)
Ex-Dividend Date2018-11-26
1y Target Est148.56
Trade prices are not sourced from all markets
  • Barrons.com13 minutes ago

    Johnson & Johnson Stock Bounces Back After the Company Reaffirms Guidance

    The consumer-health-care giant reaffirmed its full-year forecast of earnings per share of $8.13 to $8.18, on revenue of $81 billion to $81.4 billion. It also announced a $5 billion buyback plan.

  • Reuters14 minutes ago

    US STOCKS-Tech stocks, upbeat earnings boost Wall St; Fed in focus

    Wall Street rose on Tuesday, helped by technology stocks, upbeat earnings reports and a rebound in few bellwether stocks, while investors awaited clues on the Federal Reserve's path for future rate hikes. Inc was the biggest boost to the S&P and the Nasdaq and helped lift consumer discretionary stocks .

  • TheStreet.com40 minutes ago

    Dow Rises as Wall Street Attempts Rebound From Sharp Selloffs

    The Dow Jones Industrial Average rose on Tuesday for the first time in three days after closing during the previous session at its lowest level since March 23. rose 3.9% after the aerospace giant lifted its dividend by 20% and increased the size of its stock buyback program by $2 billion to $20 billion. was rising 2.5% after the software company's fiscal second-quarter adjusted earnings and revenue topped analysts' forecasts.

  • CNBC44 minutes ago

    Attorney behind a huge talc verdict: J&J's stock drop 'serves my purposes' in seeking a settlement

    Attorney Mark Lanier, who won a nearly $4.7 billion J&J talc verdict, says the recent stock plunge plays into his hands in seeking a settlement. J&J has lost roughly $50 billion in stock market value since Friday's Reuters report, alleging the company knew for decades about asbestos in baby powder. On CNBC, J&J Chairman and CEO Alex Gorsky defends the company against the Reuters report and the lawsuits like the one Lanier litigated.

  • TheStreet.com55 minutes ago

    Jim Cramer Live: Playing the Markets, Oracle, Johnson & Johnson

    "I miss the old days, the days when I when I would go home and listen to the Oracle (ORCL) conference call and think about what the impact would be for the stock market -- and the Nasdaq in particular," wrote Cramer in his Real Money column Tuesday, Dec. 18. TheStreet's Scott Rutt reported on Cramer's Mad Money show from Monday, Dec. 17. Shares of J&J plunged 10% on Friday after the story broke and another 2.9% today, wiping out over $50 billion in market cap.

  • Motley Fool1 hour ago

    Here Are Biotech’s Big Pipeline Disappointments in 2018

    A number of companies suffered setbacks this year.

  • The Wall Street Journal1 hour ago

    [$$] Stocks to Watch: Rent-A-Center, CBS, Boeing, Johnson & Johnson, Oracle, Red Hat

    Here are some of the companies with shares expected to trade actively in Tuesday’s session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified separately.

  • J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed
    Zacks1 hour ago

    J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed

    J&J's (JNJ) board authorizes a $5-billion share repurchase plan. Stock slips 2.9% on Monday, extending a 10% drop on Friday post publication of a controversial Reuters story.

  • Motley Fool2 hours ago

    Under Armour Tanks on Guidance

    The long-term picture gets better, but the short-term outlook remains rough for the beleaguered fitness apparel company.

  • Reuters2 hours ago

    US STOCKS-Wall St set to bounce from sell-off, Fed in focus

    Wall Street was set to open higher on Tuesday, after a 2-percent fall in the prior session, boosted by some strong earnings and a bounce in certain bellwether stocks as investors wait for clues on the Federal Reserve's path for future rate hikes. While investors have baked in a fourth rate hike for the year on Wednesday, turbulence in the stock markets and a host of other worries have fueled calls, including from President Donald Trump, for the Fed to pause its tightening cycle or risk harming the U.S. economy. JPMorgan Chase & Co Citigroup Inc, Goldman Sachs Group Inc and Bank of America Corp rose about 1 percent.

  • CNBC3 hours ago

    Stocks making the biggest moves premarket: DRI, FDS, NAV, ORCL, JNJ & more

    Check out the companies making headlines before the bell: Darden Restaurants DRI – The restaurant chain earned 92 cents per share for its second quarter , a penny a share above estimates. Revenue was very slightly below Street forecasts, and a same-restaurant sales increase of 2.

  • Three Megacaps Give the Market an Early Xmas Gift: Taking Stock
    Bloomberg3 hours ago

    Three Megacaps Give the Market an Early Xmas Gift: Taking Stock

    One of the more cautious equity strategists alluded to this earlier in the week: Morgan Stanley’s Mike Wilson, in discussing the many signs investors were giving up on equities, found that as expectations for 2019 become more realistic, the groundwork may be "finally" setting up for rally. The action overnight may be just what Santa Claus needed to work up that rally bulls have been waiting for what seems like forever.

  • J&J is in ‘big trouble’ but ‘may be able to weather the storm’: LJPR financial advisor
    Yahoo Finance Video23 hours ago

    J&J is in ‘big trouble’ but ‘may be able to weather the storm’: LJPR financial advisor

    Johnson and Johnson is denying the explosive report from Reuters that the company knew there was asbestos in its baby powder. Yahoo Finance’s Alexis Christoforous speaks to Managing Partner & CEO Leon LaBrecque of LJPR Financial Advisors about the pressure the company is facing.

  • Attorney behind Johnson & Johnson lawsuit speaks out
    CNBC Videos2 hours ago

    Attorney behind Johnson & Johnson lawsuit speaks out

    Mark Lanier, the attorney representing the 22 women and their families who won a lawsuit in July against Johnson & Johnson, joins 'Squawk Box' to discuss the Reuters report on the company's alleged knowledge about asbestos in its baby powder.